Literature DB >> 21186260

Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination.

Mathias Streitz1, Stephan Fuhrmann, Fiona Powell, Ali Quassem, Laurel Nomura, Holden Maecker, Peter Martus, Hans-Dieter Volk, Florian Kern.   

Abstract

Functional characteristics of tuberculosis (TB)-specific CD4 T cells were studied in clinically active pulmonary TB (n = 21) and high TB exposure including LTBI (n = 17). Following tuberculin stimulation, activated CD4 T cells were identified by flow-cytometry (CD154 up-regulation, degranulation, interferon γ [IFN-γ], tumor necrosis factor α [TNF-α], and interleukin 2 [IL-2\ production). Interestingly, CD154 up-regulation accounted for ∼80% of activated CD4 T cells in the active TB group but just 40% in the controls, whereas IFN-γ accounted for only ∼50% of activated cells in each group. The frequencies of CD4 T cells displaying at least 1 activation marker discriminated better between the groups than those displaying degranulation or IFN-γ production alone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21186260      PMCID: PMC3071115          DOI: 10.1093/infdis/jiq065

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

Review 3.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.

Authors:  Giuseppe Pantaleo; Richard A Koup
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

4.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.

Authors:  Patricia A Darrah; Dipti T Patel; Paula M De Luca; Ross W B Lindsay; Dylan F Davey; Barbara J Flynn; Søren T Hoff; Peter Andersen; Steven G Reed; Sheldon L Morris; Mario Roederer; Robert A Seder
Journal:  Nat Med       Date:  2007-06-10       Impact factor: 53.440

Review 5.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

6.  Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia.

Authors:  J Vekemans; C Lienhardt; J S Sillah; J G Wheeler; G P Lahai; M T Doherty; T Corrah; P Andersen; K P McAdam; A Marchant
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

8.  Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.

Authors:  Andreia P Soares; Thomas J Scriba; Sarah Joseph; Ryhor Harbacheuski; Rose Ann Murray; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

9.  Standardization of cytokine flow cytometry assays.

Authors:  Holden T Maecker; Aline Rinfret; Patricia D'Souza; Janice Darden; Eva Roig; Claire Landry; Peter Hayes; Josephine Birungi; Omu Anzala; Miguel Garcia; Alexandre Harari; Ian Frank; Ruth Baydo; Megan Baker; Jennifer Holbrook; Janet Ottinger; Laurie Lamoreaux; C Lorrie Epling; Elizabeth Sinclair; Maria A Suni; Kara Punt; Sandra Calarota; Sophia El-Bahi; Gailet Alter; Hazel Maila; Ellen Kuta; Josephine Cox; Clive Gray; Marcus Altfeld; Nolwenn Nougarede; Jean Boyer; Lynda Tussey; Timothy Tobery; Barry Bredt; Mario Roederer; Richard Koup; Vernon C Maino; Kent Weinhold; Giuseppe Pantaleo; Jill Gilmour; Helen Horton; Rafick P Sekaly
Journal:  BMC Immunol       Date:  2005-06-24       Impact factor: 3.615

10.  Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis.

Authors:  Mathias Streitz; Lydia Tesfa; Vedat Yildirim; Ali Yahyazadeh; Timo Ulrichs; Rodica Lenkei; Ali Quassem; Gerd Liebetrau; Laurel Nomura; Holden Maecker; Hans-Dieter Volk; Florian Kern
Journal:  PLoS One       Date:  2007-08-15       Impact factor: 3.240

View more
  9 in total

1.  Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load.

Authors:  Cheryl L Day; Deborah A Abrahams; Lesedi Lerumo; Esme Janse van Rensburg; Lynnett Stone; Terrence O'rie; Bernadette Pienaar; Marwou de Kock; Gilla Kaplan; Hassan Mahomed; Keertan Dheda; Willem A Hanekom
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

2.  Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.

Authors:  I Sauzullo; R Scrivo; F Mengoni; A Ermocida; M Coppola; G Valesini; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

3.  CD4-CD8-αβ and γδ T cells display inflammatory and regulatory potentials during human tuberculosis.

Authors:  Melina B Pinheiro; Lis R Antonelli; Renato Sathler-Avelar; Danielle M Vitelli-Avelar; Silvana Spindola-de-Miranda; Tânia M P D Guimarães; Andrea Teixeira-Carvalho; Olindo A Martins-Filho; Vicente P C P Toledo
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

4.  Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans.

Authors:  Irina Yu Nikitina; Natalya A Kondratuk; George A Kosmiadi; Rasul B Amansahedov; Irina A Vasilyeva; Vitaly V Ganusov; Irina V Lyadova
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

5.  Pulmonary immune-compartment-specific interferon gamma responses in HIV-infected individuals with active tuberculosis (TB) in an area of high TB prevalence.

Authors:  S Buldeo; D M Murdoch; M S Suchard
Journal:  Clin Dev Immunol       Date:  2012-06-21

6.  Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients.

Authors:  Mathis Steindor; Vanesa Nkwouano; Ertan Mayatepek; Colin R Mackenzie; Dirk Schramm; Marc Jacobsen
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

7.  Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.

Authors:  Norman Nausch; Daniel Antwi-Berko; Yusif Mubarik; Kabiru Mohammed Abass; Wellington Owusu; Ellis Owusu-Dabo; Linda Batsa Debrah; Alexander Yaw Debrah; Marc Jacobsen; Richard O Phillips
Journal:  PLoS Negl Trop Dis       Date:  2017-02-27

8.  Expansion of pathogen-specific mono- and multifunctional Th1 and Th17 cells in multi-focal tuberculous lymphadenitis.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Dina Nair; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

9.  Multifunctional Analysis of CD4+ T-Cell Response as Immune-Based Model for Tuberculosis Detection.

Authors:  Miriam Lichtner; Claudia Mascia; Ilaria Sauzullo; Fabio Mengoni; Serena Vita; Raffaella Marocco; Valeria Belvisi; Gianluca Russo; Vincenzo Vullo; Claudio M Mastroianni
Journal:  J Immunol Res       Date:  2015-08-03       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.